000 | 03034nam a2200361 a 4500 | ||
---|---|---|---|
001 | vtls000129206 | ||
003 | VRT | ||
005 | 20240802185152.0 | ||
008 | 141217 xxu 000 0 eng d | ||
020 | _a9781466577435 | ||
039 | 9 |
_a201504270317 _bVLOAD _c201502081557 _dVLOAD _c201501131048 _dyenh _c201501091603 _dbactt _y201412170957 _zthupt |
|
040 | _aVNU | ||
041 | 1 | _aeng | |
044 | _aUS | ||
082 | 1 |
_a616.994061 _bDNA 2013 |
|
090 |
_a616.99 _bDNA 2013 |
||
245 | 0 | 0 | _aDNA repair and cancer : from bench to clinic / editors, Srinivasan Madhusudan, David M. Wilson III. |
260 | _aBoca Raton : Taylor & Francis, 2013. | ||
300 | _a700 p. | ||
505 | _aOverview of DNA repair pathways / Deborah L. Croteau and Vilhelm A. Bohr -- Longevity assurance by genome maintenance / Paul Hasty, Yousin Suh and Jan Vijg -- Genetic instability of cancer : biological predictions and clinical implications / Robert A. Beckman -- Radiation induced DNA damage, repair, and therapeutics / Lynn Harrison -- Chemotherapeutic alkylating agents in cancer treatment / Tracey D. Bradshaw -- O6-methylguanine-DNA methyltransferase (MGMT) in cancer protection and therapy / Bernd Kaina and Markus Christmann -- DNA mismatch repair : it's role in human carcinogenesis and as a predictive and/or prognostic biomarker for cancer therapy / Timothy J. Kinsella -- DNA base excision repair therapeutics : summary of targets with a focus on APE1 / Melissa L. Fishel, Carlo Vascotto and Mark R. Kelley -- Nucleotide excision repair : DNA repair capacity variability and cancer susceptibility / Li-E Wang and Qingyi Wei -- Fanconi anemia, interstrand cross-link repair, and cancer / Taraswi Banerjee, Sanjay Kumar Bharti and Robert M. Brosh, Jr -- Functions of translesion DNA polymerases : implications for cancer risk and opportunities as therapeutic targets / Kinrin Yamanaka and R. Stephen Lloyd -- P53 in DNA damage, repair and cancer therapeutics / Aditi Gurkar, Kiki Chu and Sam W. Lee -- ATM/ATR cell cycle checkpoints : mechanisms and manipulation in cancer therapy / Marie Fernet, Sara Chiker and Janet Hall -- The BRCA1-BRCA2 pathway of homologous recombination and the opportunity for synthetic lethal approaches to cancer therapy / Laura J. Eccles ... [et al.] -- PARP and PARP inhibitor therapeutics / Nicola J. Curtin -- Tumor genetics and personalized medicine / Mary Ellen Urick and Daphne W. Bell -- The tumor microenvironment and DNA repair : implications for cancer progression and treatment / Norman Chan, Shaqil Kassam and Robert G. Bristow -- Early phase clinical trials using DNA repair inhibitors : lessons learnt / Miranda Payne and Mark Middleton. | ||
650 | 0 | _aNeoplasms--genetics. | |
650 | 0 | _aDNA Damage--drug effects. | |
650 | 0 | _aDNA Damage--physiology. | |
650 | 0 | _aDNA Repair--drug effects. | |
653 | _aBệnh ung thư | ||
653 | _aĐiều trị | ||
700 | 1 | _aMadhusudan, Srinivasan. | |
700 | 1 | _aWilson, David M., 1967- | |
900 | _aTrue | ||
925 | _aG | ||
926 | _a0 | ||
942 | _c1 | ||
999 |
_c360652 _d360652 |